Stocktoria

BICYCLE THERAPEUTICS PLC BCYC

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-05-23
Chart by TradingView
1/9
Piotroski F — financial health
5.27
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$72.6M$35.3M$27.0M$14.5M$11.7M
Operating income-$247.1M-$209.9M-$189.9M-$116.7M-$65.6M
Net income-$219.0M-$169.0M-$180.7M-$112.7M-$66.8M
Operating cash flow-$249.7M-$164.7M-$60.6M-$86.1M-$14.8M
Free cash flow-$252.0M-$166.0M-$63.6M-$105.1M-$16.8M
Total assets$717.6M$956.9M$595.3M$410.6M$479.8M
Total liabilities$107.6M$163.8M$224.4M$139.8M$133.5M
Shareholders' equity$610.0M$793.1M$370.9M$270.8M$346.3M
Ratios
Operating margin-340.4%-595.0%-704.1%-806.6%-561.0%
Net margin-301.7%-479.2%-669.7%-779.3%-571.2%
FCF margin-347.2%-470.5%-235.6%-726.7%-143.8%
Return on assets-30.5%-17.7%-30.3%-27.5%-13.9%
Return on equity-35.9%-21.3%-48.7%-41.6%-19.3%
Debt / equity0.08×0.11×0.09×
Current ratio11.9813.818.086.9212.65
Revenue growth105.8%30.8%86.5%23.6%12.6%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC979,300$4.5M
Point72 Asset Management, L.P.130,422$605,158

Why these scores methodology →

Piotroski F-score: 1/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 5.27 (safe)

  • Working capital / assets 0.872
  • Retained earnings / assets -1.254
  • EBIT / assets -0.344
  • Equity / liabilities 5.668

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001761612 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.